Chromogranin A Antikörper (C-Term)
Kurzübersicht für Chromogranin A Antikörper (C-Term) (ABIN7598846)
Target
Alle Chromogranin A (CHGA) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 427-453, C-Term
-
Verwendungszweck
- Anti-Chromogranin A
-
Spezifität
- Chromogranin A
-
Immunogen
- Peptide derived from C-terminal sequence of human chromogranin A. Antibody recognizes the epitope between Arg427 - Ala453.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- +2 °C to +8 °C
-
-
- Chromogranin A (CHGA)
-
Andere Bezeichnung
- Chromogranin A
-
Hintergrund
- Chromogranin A is a major member of the family of acidic secretory glycoproteins, expressed in all endocrine and neuroendocrine cells. Chromogranin A expression has been detected in number of neuroendocrine tumors, including phaeochromocytomas, medullary thyroid carcinomas, pituitary adenomas and Merkel cell tumors.
-
UniProt
- P10645
-
Pathways
- Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling
Target
-